These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37150879)

  • 1. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VM; Lee EB; Hansson O
    medRxiv; 2023 Feb; ():. PubMed ID: 36778217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
    Woodworth DC; Nguyen KM; Sordo L; Scambray KA; Head E; Kawas CH; Corrada MM; Nelson PT; Sajjadi SA
    Acta Neuropathol; 2024 Jun; 147(1):103. PubMed ID: 38896163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies.
    Robinson JL; Suh E; Xu Y; Hurtig HI; Elman L; McMillan CT; Irwin DJ; Porta S; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2024 Jun; 147(1):104. PubMed ID: 38896345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.
    Robinson JL; Porta S; Garrett FG; Zhang P; Xie SX; Suh E; Van Deerlin VM; Abner EL; Jicha GA; Barber JM; Lee VM; Lee EB; Trojanowski JQ; Nelson PT
    Brain; 2020 Sep; 143(9):2844-2857. PubMed ID: 32830216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA
    Brain; 2019 Jun; 142(6):1503-1527. PubMed ID: 31039256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.
    Prater KE; Latimer CS; Jayadev S
    Glia; 2022 Feb; 70(2):239-255. PubMed ID: 34558120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
    Carlos AF; Josephs KA
    J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies.
    Ho PC; Hsieh TC; Tsai KJ
    Ageing Res Rev; 2024 Sep; 100():102441. PubMed ID: 39069095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LATE-NC staging in routine neuropathologic diagnosis: an update.
    Nelson PT; Lee EB; Cykowski MD; Alafuzoff I; Arfanakis K; Attems J; Brayne C; Corrada MM; Dugger BN; Flanagan ME; Ghetti B; Grinberg LT; Grossman M; Grothe MJ; Halliday GM; Hasegawa M; Hokkanen SRK; Hunter S; Jellinger K; Kawas CH; Keene CD; Kouri N; Kovacs GG; Leverenz JB; Latimer CS; Mackenzie IR; Mao Q; McAleese KE; Merrick R; Montine TJ; Murray ME; Myllykangas L; Nag S; Neltner JH; Newell KL; Rissman RA; Saito Y; Sajjadi SA; Schwetye KE; Teich AF; Thal DR; Tomé SO; Troncoso JC; Wang SJ; White CL; Wisniewski T; Yang HS; Schneider JA; Dickson DW; Neumann M
    Acta Neuropathol; 2023 Feb; 145(2):159-173. PubMed ID: 36512061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy.
    Katsumata Y; Abner EL; Karanth S; Teylan MA; Mock CN; Cykowski MD; Lee EB; Boehme KL; Mukherjee S; Kauwe JSK; Kryscio RJ; Schmitt FA; Fardo DW; Nelson PT
    Acta Neuropathol; 2020 Nov; 140(5):659-674. PubMed ID: 32797255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration.
    Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR
    Neurobiol Aging; 2021 Nov; 107():11-20. PubMed ID: 34371283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.
    Janssens J; Van Broeckhoven C
    Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.